BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production

Our valued customer Nouscom recently proclaimed that their sub-licensee, has initiated phase 1 clinical trials for VAC85135, a viral vector-based cancer va...

January 18, 2023 | News

SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia

The world-second developed shingles vaccine 'SKYZoster™' is approved by the National Pharmaceutical Regulatory Agency (NPRA) SK biosciences p...

January 10, 2023 | News

Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates

The dose-confirming trial will evaluate the safety and effectiveness (immunogenicity) of different formulations of the CIC and influenza vaccine candidates...

January 02, 2023 | News

China to downgrade COVID-19 management to Class B

In a statement released late Monday, the National Health Commission (NHC) renamed the Chinese term for COVID-19 from "novel coronavirus pneumonia" to "nove...

December 28, 2022 | News

Everest Medicines Announces New mRNA Rabies Vaccine Program and Achievement of Preclinical Proof-of-Concept Milestone

Rabies program, as the first non-COVID19 vaccine developed with a specialized mRNA platform, highlights Everest's discovery capabilities Clinically valida...

December 15, 2022 | News

China further optimizes COVID-19 response with new measures

Local authorities across China have soon made specific policies to implement the 10 new prevention and control measures recently rolled out by th...

December 12, 2022 | News

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years

Bivalent vaccine authorized as third 3-µg dose in the three-dose primary series Consistent COVID-19 hospitalization rates in this age group couple...

December 08, 2022 | News

Evonik launches plant-based squalene to boost vaccine efficacy

Sustainable alternative to squalene extracted from shark liver oil Adjuvant component for parenteral drug delivery applications Increases share of next...

December 06, 2022 | News

Griffith joins $280 million partnership to deliver mRNA vaccine outcomes

The $280 million Translational Science Hub will be established under an agreement between Sanofi, Griffith University, the University of Queensland and the...

December 05, 2022 | News

BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine

The complete manufacturing of BVX-0918 from a cancer patient's ovarian tumor now validates the production protocols that had been in development over the p...

December 02, 2022 | News

XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development

AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients worldwide...

November 25, 2022 | News

Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China

MVA-BN RSV, is being developed for the prevention of respiratory syncytial virus (RSV) in older adults. The vaccine incorporates five distinct RSV antigens...

November 15, 2022 | News

YS Biopharma Announces US FDA Clearance Of IND Application For PIKA COVID-19 vaccine

PIKA COVID-19 vaccine is composed of PIKA adjuvant and a stable trimeric form of the recombinant SARS-CoV-2 spike (S) protein as the main antigen component...

November 11, 2022 | News

EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine

This program is funded under CEPI's 2021 call for proposals to accelerate the development of broadly protective coronavirus vaccines, which will ...

November 01, 2022 | News

Stay Connected